PAYING FOR CURES: AN ANALYSIS OF INNOVATIVE ACCESS AGREEMENTS FOR LICENSED GENE THERAPIES

被引：0
|
作者：
Hogg, L. [1 ]
Richards, M. [1 ]
机构：
[1] Ipsos, London, England
来源：
VALUE IN HEALTH | 2019年 / 22卷
关键词：
D O I：
暂无
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
PBI77
引用
收藏
页码：S431 / S431
页数：1
相关论文
共 50 条
  • [1] DIFFERENT TYPES OF INNOVATIVE MODELS FOR PAYING FOR GENE THERAPIES - ADVANTAGES AND POSSIBLE LIMITATIONS
    Dacheva, A.
    Djambazov, S.
    Vutova, Y.
    Slavchev, G.
    VALUE IN HEALTH, 2022, 25 (12) : S59 - S59
  • [2] INNOVATIVE APPROACHES FOR PATIENT ACCESS TO GENE THERAPIES IN HAEMOPHILIA
    Ermacora, P.
    Meszarosova, D.
    Ong, A. D.
    Carr, D.
    VALUE IN HEALTH, 2020, 23 : S418 - S418
  • [3] ARE MANAGED ENTRY AGREEMENTS A FEASIBLE APPROACH TO IMPROVE PATIENT ACCESS TO INNOVATIVE THERAPIES IN LATIN AMERICA?
    Caruso, Amaris A.
    Perez, A., V
    Guarin, D.
    Dorling, W.
    Chaves Cardona, R.
    Castro, H.
    VALUE IN HEALTH, 2022, 25 (12) : S256 - S256
  • [4] CONDITIONAL AGREEMENTS FOR INNOVATIVE THERAPIES IN ITALY: THE CASE OF PIRFENIDONE
    Fasci, A.
    Ferrario, M.
    Ravasio, R.
    Ena, R.
    Angelini, S.
    Giuliani, G.
    VALUE IN HEALTH, 2015, 18 (07) : A505 - A505
  • [5] PAYING FOR GENE THERAPIES: APPROACHING A SUSTAINABLE SOLUTION
    Spark, Y. M.
    Sear, R.
    Hutchings, A.
    VALUE IN HEALTH, 2017, 20 (09) : A685 - A685
  • [6] Application of Managed Entry Agreements for Innovative Therapies in Different Settings and Combinations: A Feasibility Analysis
    Vreman, Rick
    Broekhoff, Thomas
    GM Leufkens, Hubert
    Mantel-Teeuwisse, Aukje
    Goettsch, Wim
    INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH, 2020, 17 (22) : 1 - 20
  • [7] INVISIBLE LEVER FOR ACCESS TO INNOVATIVE THERAPIES IN BULGARIA
    Dobreva, D. P.
    Petrova, T.
    VALUE IN HEALTH, 2016, 19 (07) : A719 - A719
  • [8] Update in gene therapies or innovative therapies in aniridia associated keratopathy
    Bremond-Gignac, Dominique
    ACTA OPHTHALMOLOGICA, 2024, 102
  • [9] Equal access to innovative therapies and precision cancer care
    Agnès Buzyn
    Jean-Yves Blay
    Natalie Hoog-Labouret
    Marta Jimenez
    Frédérique Nowak
    Marie-Cécile Le Deley
    David Pérol
    Christian Cailliot
    Jacques Raynaud
    Gilles Vassal
    Nature Reviews Clinical Oncology, 2016, 13 : 385 - 393
  • [10] Equal access to innovative therapies and precision cancer care
    Buzyn, Agnes
    Blay, Jean-Yves
    Hoog-Labouret, Natalie
    Jimenez, Marta
    Nowak, Frederique
    Le Deley, Marie-Cecile
    Perol, David
    Cailliot, Christian
    Raynaud, Jacques
    Vassal, Gilles
    NATURE REVIEWS CLINICAL ONCOLOGY, 2016, 13 (06) : 385 - 393
12345